25010-710 : Syprine 250 mg Oral Capsule
NDC: | 25010-710 |
Labeler: | Aton Pharma, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Oral Capsule |
Application #: | NDA019194 |
Rev. Date: |
Appearance:
Markings: | Aton;710;Syprine |
Shapes: |
Capsule |
Colors: |
![]() |
Size (mm): | 19 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
![Aton 710 Syprine: (25010-710) Syprine 250 mg Oral Capsule by Aton Pharma, Inc. Aton 710 Syprine: (25010-710) Syprine 250 mg Oral Capsule by Aton Pharma, Inc.](/images/NDC/25010-710.jpg)
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 25010-710-15: 1 BOTTLE IN 1 CARTON (25010‑710‑15) > 100 CAPSULE IN 1 BOTTLE
Active Ingredients:
- Trientine Hydrochloride
Dosage Strength:
- 250 mg
Inactive Ingredients:
- Gelatin
- Stearic Acid
- Titanium Dioxide
Pharmaceutical Classes:
- Metal Chelating Activity [MoA]
- Metal Chelator [EPC]
Related Products:
Based on records with the same trade name.- 0187-2120 Syprine 250 mg Oral Capsule by Valeant Pharmaceuticals North America LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:![NDC 25010-710 QR Code](/images/NDC-QR/25010-710-QR.png)
< Prev: 25010-705Next: 25010-711 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.